Dr. Silverstein answers: 'What If More Cancer is Found During Lumpectomy?' — -- Question: What will the surgeon do if more cancer is evident during lumpectomy surgery? Answer: If more cancer is ...
The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...
Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...
As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...
Lumpectomy could be better for a breast cancer patient’s future sex life Sexual well-being scores improved following a lumpectomy Women who got a mastectomy followed by breast reconstruction had lower ...
(HealthDay News) — In a study of 241 ,597 women who had breast conservation surgery for breast cancer, 23.6% needed a second operation. The report was published online November 12 in JAMA Surgery. Lee ...
Larger breast size, diabetes, and smoking history may be factors of increased volume loss whether whole- or partial-breast radiation was administered. HealthDay News — Patients with T1 tumors ...
The FDA has granted the ProSense Cryoablation System marketing authorization for small, low-risk breast cancers in women at least 70 years of age who receive adjuvant endocrine therapy. The ...
Hosted on MSN
What to Expect During Your Lumpectomy Recovery
Most people recover from lumpectomy surgery in around two weeks, though this can vary depending on the extent of the surgery and your overall health. You may be able to resume normal activities within ...
MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST ...
Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group PURPOSE: To develop an instrument to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback